16 unknown. 16 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Unknown 16 |
| Phase 1 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Mitomycin: new trials by email Literature Review of Mitomycin trials Research Report on Mitomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Mitomycin, Lobaplatin - Colorectal Cancer, Chemotherapy Effect | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 201 | 2022-09-01 | 2022-02-21 |
| A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study nivolumab 480mg, nivolumab 3mg/kg, ipilimumab 1mg/kg, nivolumab 1mg/kg, ipilimumab 3mg/kg - Urinary Bladder Cancer, Invasive Bladder Cancer | Phase 1 / Phase 2 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 50 | 2019-01-07 | 2022-08-12 |
| Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis Mitomycin c, Melphalan - Cancer, Appendiceal, ColoRectal Cancer | Phase 2 | Unknown | University of Kansas Medical Center | 100 | 2017-07-14 | 2023-06-09 |
| Proton Therapy in Reducing Toxicity in Anal Cancer Proton therapy, Chemotherapy - Anus Neoplasms | Phase 2 | Unknown | Jordan Kharofa | 14 | 2017-01-04 | 2024-09-19 |
| Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer Chemo-radiotherapy with IMRT technique, Capecitabine, Mitomycin C - Anal Cancer | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 27 | 2015-12-02 | 2018-01-30 |
| Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma TACE, Dendritic Cell, lipiodol - Recurrence Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | Second Military Medical University | 60 | 2015-09-01 | 2016-01-01 |
| Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer Mitomycin C, Surgical Management - Bladder Cancer | Phase 2 | Unknown | Institute of Cancer Research, United Kingdom | 82 | 2014-10-01 | 2020-03-19 |
| The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements Mitomycin-C, Fluorometholone 1% topical ocular steroid - Corneal Opacity | Phase 2 / Phase 3 | Unknown | United States Naval Medical Center, San Diego | 300 | 2014-08-01 | 2022-04-15 |
| Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis Mitomycin C, Normal saline - Primary Sclerosing Cholangitis | Phase 2 | Unknown | Li, Zhiping, M.D. | 130 | 2012-09-01 | 2016-09-07 |
| Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor Oxaliplatin, Mitomycin + Gemcitabine - Liver Metastasis | Phase 2 | Unknown | Copenhagen University Hospital at Herlev | 100 | 2011-07-01 | 2012-01-19 |
| Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis cytoreductive surgery, intraoperative peritoneal hyperthermic chemotherapy with cisplatin and mitomycin - Stomach Neoplasms, Colorectal Neoplasms | Phase 2 | Unknown | Wuhan University | 60 | 2007-03-01 | 2009-02-13 |
| Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer Capecitabine and Mitomycin C - Breast Cancer, Metastasis | Phase 2 | Unknown | Croatian Cooperative Group for Clinical Research in Oncology | 39 | 2006-03-01 | 2010-09-08 |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer recombinant interferon gamma, cisplatin, doxorubicin hydrochloride - Malignant Mesothelioma | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2001-05-01 | 2014-01-06 | |
| Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma cisplatin, mitomycin C, vinblastine sulfate - Malignant Mesothelioma | Phase 2 | Unknown | British Thoracic Society | 2000-11-01 | 2013-08-07 | |
| Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer cisplatin, mitomycin C, tretinoin - Lung Cancer | Phase 2 | Unknown | Raghu Nandan, M.D., Inc | 1998-09-01 | 2013-12-18 | |
| Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer chemotherapy, fluorouracil, leucovorin calcium - Carcinoma of the Appendix, Colorectal Cancer | Phase 2 | Unknown | Gustave Roussy, Cancer Campus, Grand Paris | 1996-01-01 | 2011-04-26 |
Colorectal Neoplasms (4) · Neoplasm Metastasis (3) · Anus Neoplasms (2) · Appendiceal Neoplasms (2) · Mesothelioma, Malignant (2) · Peritoneal Neoplasms (2) · Urinary Bladder Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangitis, Sclerosing (1) · Colonic Neoplasms (1) · Corneal Opacity (1) · Lung Neoplasms (1) · Mesothelioma (1) · Rectal Neoplasms (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · British Thoracic Society (1) · Chinese Academy of Medical Sciences (1) · Copenhagen University Hospital at Herlev (1) · Croatian Cooperative Group for Clinical Research in Oncology (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Herbert Irving Comprehensive Cancer Center (1) · Institute of Cancer Research, United Kingdom (1) · Jordan Kharofa (1) · Li, Zhiping, M.D. (1) · Raghu Nandan, M.D., Inc (1) · Second Military Medical University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · United States Naval Medical Center, San Diego (1) · University of Kansas Medical Center (1)
United States (6) · China (3) · United Kingdom (2) · Croatia (1) · Denmark (1) · France (1) · Netherlands (1)
Adriaan D. Bins, MD PhD (1) · David J. Girling, MD (1) · Dominique Elias, MD (1) · Donna Murdoch, Ph.D. (1) · Eduard Vrdoljak, MD PhD (1) · Feng Shen, PHD (1) · Finn O Larsen, M.D., Ph.D (1) · Hugh Mostafid (1) · John B Cason, M.D. (1) · Jordan Kharofa, MD (1) · Kaixiong Tao, Professor (1) · Martin F. Muers, MD (1) · Mazin Al-kasspooles, MD (1) · Raghu Nandan, MD (1) · Robert N. Taub, MD, PhD (1)
PMID 22287157, PMID 22831982, PMID 25680955, PMID 27633880, PMID 32124514, PMID 32306237, PMID 37690994